AU2015367208B2 - Formulations of calcium and phosphate for oral inflammation - Google Patents

Formulations of calcium and phosphate for oral inflammation Download PDF

Info

Publication number
AU2015367208B2
AU2015367208B2 AU2015367208A AU2015367208A AU2015367208B2 AU 2015367208 B2 AU2015367208 B2 AU 2015367208B2 AU 2015367208 A AU2015367208 A AU 2015367208A AU 2015367208 A AU2015367208 A AU 2015367208A AU 2015367208 B2 AU2015367208 B2 AU 2015367208B2
Authority
AU
Australia
Prior art keywords
powder
oral
alternatively
calcium
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015367208A
Other languages
English (en)
Other versions
AU2015367208A1 (en
Inventor
Aimesther BETANCOURT
Sandryne DUMOULIN
Patrick Gosselin
Edward Kobus
Bartholomew Weldon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch Health Companies Inc
Original Assignee
Bausch Health Companies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch Health Companies Inc filed Critical Bausch Health Companies Inc
Publication of AU2015367208A1 publication Critical patent/AU2015367208A1/en
Assigned to BAUSCH HEALTH COMPANIES INC. reassignment BAUSCH HEALTH COMPANIES INC. Amend patent request/document other than specification (104) Assignors: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Application granted granted Critical
Publication of AU2015367208B2 publication Critical patent/AU2015367208B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2015367208A 2014-12-17 2015-12-15 Formulations of calcium and phosphate for oral inflammation Active AU2015367208B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462093026P 2014-12-17 2014-12-17
US62/093,026 2014-12-17
PCT/CA2015/051327 WO2016095036A1 (en) 2014-12-17 2015-12-15 Formulations of calcium and phosphate for oral inflammation

Publications (2)

Publication Number Publication Date
AU2015367208A1 AU2015367208A1 (en) 2017-08-03
AU2015367208B2 true AU2015367208B2 (en) 2021-04-01

Family

ID=56125518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015367208A Active AU2015367208B2 (en) 2014-12-17 2015-12-15 Formulations of calcium and phosphate for oral inflammation

Country Status (10)

Country Link
US (2) US11590165B2 (enExample)
EP (1) EP3233092B1 (enExample)
JP (1) JP6781701B2 (enExample)
KR (1) KR102397070B1 (enExample)
CN (1) CN107530374B (enExample)
AU (1) AU2015367208B2 (enExample)
BR (1) BR112017013158B1 (enExample)
CA (1) CA2971224C (enExample)
MX (1) MX372952B (enExample)
WO (1) WO2016095036A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10765650B2 (en) * 2016-02-03 2020-09-08 Forward Science Technologies, LLC Artificial saliva
US10143635B2 (en) * 2016-02-03 2018-12-04 Forward Science Technologies, LLC Artificial saliva
GR1009399B (el) * 2017-06-23 2018-11-15 Χρηστος Γεωργιου Φυτας Στοματικο διαλυμα κατα της ξηροστομιας και στοματοφαρυγγικης βλεννογονιτιδας
WO2023183556A2 (en) * 2022-03-24 2023-09-28 Amcyte Pharma, Inc. Treatment for retinal disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112193A1 (en) * 2003-07-23 2005-05-26 Phillips Jeffrey O. Immediate-release formulations of acid-labile pharmaceutical compositions
WO2010054494A2 (en) * 2008-11-14 2010-05-20 Profimed S.R.O. Biomimetic oral care composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB572352A (en) * 1944-02-26 1945-10-03 Charles Somerville Dillon Improved tooth powder or preparation
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5540913A (en) 1987-03-17 1996-07-30 Turner; Robert E. Formulations and uses thereof in the prevention and treatment of oral lesions
US5268267A (en) 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
US5427768A (en) 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
AU695356B2 (en) * 1995-02-24 1998-08-13 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
MX9801063A (es) 1995-08-08 1998-05-31 Enamelon Inc Productos y metodos mejorados para la remineralizacion de lesiones en dientes.
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
PT939613E (pt) * 1996-09-18 2003-07-31 Erling Johansen Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato
US6159448A (en) * 1996-09-27 2000-12-12 Enamelon, Inc. Products and methods for the remineralization and prevention of demineralization of teeth
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
JP4669960B2 (ja) 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
US20070185194A1 (en) * 2003-07-01 2007-08-09 Kamal Mehta Stable oral compositions of azithromycin monohydrate
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
US8518383B2 (en) 2006-02-03 2013-08-27 Wm. Wrigley Jr. Company Oral care products comprising buffer systems for improved mineralization/remineralization benefits
MX2008012524A (es) * 2006-04-05 2008-10-10 Cadbury Adams Usa Llc Complejo de fosfato de calcio y sales en sistemas de liberacion oral.
TWI445540B (zh) * 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
JP5166780B2 (ja) * 2007-06-20 2013-03-21 花王株式会社 液体口腔用組成物
US20090023771A1 (en) * 2007-07-18 2009-01-22 The Curators Of The University Of Missouri Pharmaceutical composition comprising a proton pump inhibitor and protein component
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US20090130232A1 (en) 2007-11-20 2009-05-21 Mohammed Zahra Composition and method for treatment of oral inflammation an ulceration
US20090239957A1 (en) * 2007-12-21 2009-09-24 Alcon Research, Ltd. Stabilized glycerophosphate-containing surgical irrigating solution
CN101980700A (zh) * 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
JP2009235012A (ja) 2008-03-28 2009-10-15 Gc Corp 口腔湿潤用組成物
CN101584889B (zh) 2009-07-10 2012-12-12 山东大学威海分校 一种用于治疗牙周病的外用原位成型基质
US20110086108A1 (en) 2009-10-12 2011-04-14 Bartholomew Weldon Dissolving powders that can be mixed with water and used as an oral rinse
JP5485677B2 (ja) 2009-12-16 2014-05-07 花王株式会社 口腔用組成物
KR102120160B1 (ko) * 2010-08-07 2020-06-08 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 구강용 조성물
US11090259B2 (en) * 2012-11-16 2021-08-17 Eusa Pharma (Uk) Ltd Effervescent tablet

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112193A1 (en) * 2003-07-23 2005-05-26 Phillips Jeffrey O. Immediate-release formulations of acid-labile pharmaceutical compositions
WO2010054494A2 (en) * 2008-11-14 2010-05-20 Profimed S.R.O. Biomimetic oral care composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
E. Z. Levin, URL: https://www.dentalacademyofce.com/courses/2615%2FPDF%2F1405cei_Levin_web.pdf *

Also Published As

Publication number Publication date
EP3233092A4 (en) 2018-08-01
US20160175356A1 (en) 2016-06-23
AU2015367208A1 (en) 2017-08-03
JP6781701B2 (ja) 2020-11-04
KR102397070B1 (ko) 2022-05-16
CA2971224A1 (en) 2016-06-23
KR20170105517A (ko) 2017-09-19
BR112017013158B1 (pt) 2023-05-02
EP3233092A1 (en) 2017-10-25
US11590165B2 (en) 2023-02-28
US20230241102A1 (en) 2023-08-03
CN107530374B (zh) 2021-07-27
CA2971224C (en) 2020-09-22
MX2017007741A (es) 2018-05-02
WO2016095036A1 (en) 2016-06-23
BR112017013158A2 (pt) 2018-04-10
CN107530374A (zh) 2018-01-02
EP3233092B1 (en) 2019-09-04
MX372952B (es) 2020-04-03
JP2018505862A (ja) 2018-03-01

Similar Documents

Publication Publication Date Title
US20230241102A1 (en) Formulations of calcium and phosphate for oral inflammation
CN104023796B (zh) 口腔护理组合物
CN103271836A (zh) 非细胞毒性的二氧化氯流体
EP2520279A1 (en) Thermoreversible gel pharamaceutical compositions for odontoiatric use
CN102264636A (zh) 用于减少牙齿的脱矿质的组合物和方法
CN108289823A (zh) 口腔用组合物
CN105078781B (zh) 龋齿的无创伤治疗用的木瓜蛋白酶牙科用凝胶组合物及其制备方法
DE202016102375U1 (de) Dentales Mittel auf Basis von Hyaluronan und Octenidindihydrochlorid
JP7359909B2 (ja) 口腔用組成物の製造方法、口腔用組成物の口腔内塗布部との密着性を向上させる方法および口腔用組成物の口腔内塗布部における滞留性を向上させる方法。
US9433644B2 (en) Formulations and methods for treating oral inflammation, injury, or pain
CN101072550A (zh) 稳定的氧释放组合物
RU2238078C1 (ru) Лечебно-профилактическое средство местного действия в виде самоклеящейся пленки для реминерализации твердых тканей зубов
AU2013329086B2 (en) Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
JP2006117539A (ja) 油性軟膏剤
WO2005079747A1 (en) Pharmaceutical preparation for the oral cavity
JP3969587B2 (ja) アズレンスルホン酸ナトリウム製剤
RU2473327C2 (ru) Композиция для борьбы с эпистаксисом
RU2712085C1 (ru) Средство для ухода за полостью рта
CN106580941B (zh) 一种含有薁磺酸钠的漱口散剂及其制备方法
JPS6147414A (ja) 軟膏の基剤

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: BAUSCH HEALTH COMPANIES INC.

Free format text: FORMER NAME(S): VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

FGA Letters patent sealed or granted (standard patent)